In this week’s edition of InnovationRx, we look at Sarepta’s showdown with the FDA, Moderna’s use of quantum computers, a new top drug regulator at the FDA, ARCH Venture’s latest biotech company, and more. Usually when the FDA asks a drugmaker to halt distribution of a treatment, the company complies.Last week, in a remarkable showdown, […]
